Attessa Capital LLC
Filing Date
Global Rank
#6,499
/ 8,586
▲ 115
Top Industry
Consumer Electronics
20.3%
3Y Alpha vs SPY
-0.6%
Period ended 3 months ago
Filed Apr 7, 2026 · 2mo
6 quarters · since Dec 2024
Clone Performance
Feb 2025–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+24.9%
SPY
+25.8%
Annualised alpha
-0.6%
Max drawdown
−18.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
13 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
90.1%
−0.0 pts
Top 5
95.9%
−0.3 pts
Top 10
99.1%
−0.2 pts
HHI
8,130
Highly concentrated−4
Portfolio Trend
6 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 90.5% | $57,616,742 |
| Technology | 3.3% | $2,111,844 |
| Consumer Cyclical | 1.9% | $1,183,280 |
| Financial Services | 1.5% | $956,500 |
| Healthcare | 1.3% | $814,737 |
| Energy | 1.0% | $610,436 |
| Consumer Defensive | 0.6% | $369,857 |
Last Quarter's Activity
Export CSVNew Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PDI | PIMCO Dynamic Income Fund | 10,782 | $184,480 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
2 positions ·
$814,737 total
· Healthcare only
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ABT |
Abbott Laboratories
Healthcare
|
Held | 2,610 | $267,968 | 32.89% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Reduced | 2,514 | $546,769 | 67.11% |